All Clinical Trials in Canada

A listing of 3905 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

Canada

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal Lesions

NCT04242589

Recruiting

Since patients with spinal metastases are living longer, durable palliation with long-term tumor control are becoming increasingly important. EBRT results in durable local control of bone metastasis. However, about 25 % of patients with spinal metastases only achieved complete pain relief following EBRT for a median duration of less than 4 months. This could be partly due to spinal instability. In addition, almost half of the patients who receive EBRT will subsequently develop VCFs . Hence, RT... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/24/2025

Locations: Cross Cancer Institute, Edmonton, Alberta

Conditions: Spinal Metastases

Learn More ›

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

NCT03435796

Recruiting

This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one infusion of GM T cells will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.

Gender:

ALL

Ages:

All

Trial Updated:

06/24/2025

Locations: University of Alabama Birmingham, Birmingham, Alabama +181 locations

University of Alabama Birmingham, Birmingham, Alabama

Banner MD Anderson Cancer Center, Gilbert, Arizona

Mayo Clinic Phoenix, Phoenix, Arizona

Arizona Cancer Center, Scottsdale, Arizona

Local Institution - 01021, Tucson, Arizona

City Of Hope, Duarte, California

University Of California San Diego Moores Cancer Center, La Jolla, California

Local Institution - 01206, Los Angeles, California

Local Institution - 01043, Sacramento, California

University of California, San Francisco- California, San Francisco, California

UCLA Medical Centre-Santa Monica, Santa Monica, California

Stanford Cancer Center, Stanford, California

University Of Colorado Cancer Center, Aurora, Colorado

Colorado Blood Cancer Institute, Denver, Colorado

Yale Cancer Center, New Haven, Connecticut

Local Institution - 01050, Washington, District of Columbia

The Mayo Clinic - Jacksonville, Davis-E, Jacksonville, Florida

Baptist Cancer Center, Miami, Florida

Local Institution - 01035, Orlando, Florida

H. Lee Moffitt Cancer Center and Research Institute University of South Florida, Tampa, Florida

Winship Cancer Institute of Emory University, Atlanta, Georgia

Northside Hospital, Inc, Atlanta, Georgia

Northwestern Memorial Hospital, Chicago, Illinois

University Of Chicago Medical Center, Chicago, Illinois

Local Institution - 01040, Maywood, Illinois

Local Institution - 01063, Niles, Illinois

IN Univ Simon Cancer Center, Indianapolis, Indiana

Local Institution - 01020, Indianapolis, Indiana

Kansas University Medical Center, Westwood, Kansas

Cancer Center of Kansas, Wichita, Kansas

University Of Kentucky, Lexington, Kentucky

Norton Cancer Institute Louisville Oncology, Louisville, Kentucky

Local Institution - 01026, New Orleans, Louisiana

University of Maryland - Greenebaum Comprehensive Cancer Center, Baltimore, Maryland

Sidney Kimmel Comp Cancer Center at Johns Hopkins, Baltimore, Maryland

National Cancer Institute, Bethesda, Maryland

Local Institution - 01107, Boston, Massachusetts

Massachusetts General Hospital / Dana-Farber Cancer Institute, Boston, Massachusetts

Local Institution - 01106, Boston, Massachusetts

University Of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Karmanos Cancer Center Wayne State University, Detroit, Michigan

Providence Cancer Institute, Southfield, Michigan

M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis, Minnesota

Mayo Clinic, Rochester, Minnesota

Siteman Cancer Center, Saint Louis, Missouri

University Of Nebraska Medical Center, Omaha, Nebraska

Local Institution - 01030, East Brunswick, New Jersey

Hackensack University Medical Center, Hackensack, New Jersey

Morristown Memorial Hosp, Morristown, New Jersey

Local Institution - 01053, New Brunswick, New Jersey

New York Oncology Hematology P.C., Albany, New York

Roswell Park Cancer Institute, Buffalo, New York

Local Institution - 01066, New York, New York

Weill Cornell Medicine / New York Presbyterian Hospital, New York, New York

Icahn School Of Medicine At Mount Sinai, New York, New York

Columbia University Medical Center/New York-Presbyterian Hospital, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Local Institution - 01051, Rochester, New York

Levine Cancer Institute, Charlotte, North Carolina

Duke University Medical Center, Durham, North Carolina

Novant Health, Salisbury, North Carolina

Oncology Hematology Care, Inc., Cincinnati, Ohio

University Hospitals of Cleveland, Cleveland, Ohio

Cleveland Clinic Foundation, Cleveland, Ohio

Local Institution - 01074, Columbus, Ohio

University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City, Oklahoma

Willamette Valley Cancer Institute, Eugene, Oregon

Providence Portland Medical Center, Portland, Oregon

Oregon Health and Science University OHSU, Portland, Oregon

Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia, Pennsylvania

University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania

Thomas Jefferson University - Clinical Research Institute, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

UPMC Cancer Pavillion, Pittsburgh, Pennsylvania

Hematology and Oncology Associates of SC, LLC, Greenville, South Carolina

Local Institution - 01064, Sioux Falls, South Dakota

Sarah Cannon Research Inst, Nashville, Tennessee

Texas Oncology, Dallas, Texas

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas

UT Southwestern Medical Center, Dallas, Texas

University of Texas- MD Anderson, Houston, Texas

Sam Clinical Research Center, San Antonio, Texas

Local Institution - 01033, Temple, Texas

Texas Oncology, P.A. - Tyler, Tyler, Texas

University of Utah - Huntsman Cancer Institute, Salt Lake City, Utah

Intermountain Healthcare - LDS Hospital, Salt Lake City, Utah

University Of Virginia Health System, Charlottesville, Virginia

Local Institution - 01045, Norfolk, Virginia

Local Institution - 01023, Richmond, Virginia

Swedish Cancer Institute, Seattle, Washington

Local Institution - 01060, Seattle, Washington

Fred Hutchinson Cancer Center, Seattle, Washington

Local Institution - 01055, Tacoma, Washington

University Of Wisconsin, Madison, Wisconsin

Froedtert Hospital BMT Medical College of Wisconsin, Milwaukee, Wisconsin

Local Institution - 01069, Wauwatosa, Wisconsin

Peter MacCallum Cancer Centre, Melbourne, Victoria

The Alfred Hospital, Melbourne, Victoria

Fiona Stanley Hospital, Murdoch, Western Australia

Allgemeinen Krankenhaus (AKH) Wien - Medizinische Universitaet Wien, Wien, Not set

Jules Bordet Institut, Anderlecht, Not set

Universitair Ziekenhuis Brussel, Brussel, Not set

Local Institution - 05200, Gent, Not set

Uz Gent, Gent, Not set

University Hospital Leuven, Leuven, Not set

Local Institution - UNK 2, Leuven, Not set

University Of Calgary, Calgary, Alberta

Local Institution - 02802, Vancouver, British Columbia

Local Institution - 02801, Hamilton, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

CIUSSS de l'Est-de-l'Ile-de-Montreal, Montreal, Quebec

Helsinki University Central Hospital (HUCH), Helsinki, Not set

Hopital Henri Mondor, Creteil-Paris, Not set

CHRU de Lille France, Lille Cedex, Not set

Local Institution - 09601, Lyon, Not set

Local Institution - 09400, Marseille Cedex 9, Not set

Local Institution - 09602, Marseille Cedex 9, Not set

CHU Montpellier - Hôpital Saint Eloi, Montpellier CEDEX 5, Not set

Chu Hotel Dieu, Nantes Cedex 01, Not set

Hopital Saint Louis, Paris, Not set

Hospital Saint Louis, Paris, Not set

Local Institution - 09600, Paris, Not set

Centre Hospitalier Universitaire (CHU) de Bordeaux - Hopital Haut-Leveque, Pessac, Not set

Centre Hospitalier Lyon-Sud, Pierre-Benite CEDEX, Not set

CHU La Miletrie, Poitiers Cedex, Not set

Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse CEDEX 9, Not set

Gustave Roussy, Villejuif, Not set

Robert-Rossle-Klinik im HELIOS Klinikum Berlin-Buch Klinik fur Hamatologie, Onkologie u. Tumorimmuno, Berlin, Not set

Local Institution - 03155, Berlin, Not set

Universitatsklinikum Carl Gustav Carus an der TU Dresden, Dresden, Not set

Local Institution - 03513, Dusseldorf, Not set

Local Institution - 03500, Frankfurt, Not set

Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Not set

Universitatsklinikum Heidelberg, Heidelberg, Not set

Kinikum der Universitaeat zu Koeln, Koeln, Not set

Local Institution - 03454, Muenster, Not set

LMU Klinikum der Universität, München, Not set

Local Institution - 03503, Tuebingen, Not set

University Hospital of Ulm, Ulm, Not set

Universitatsklinikum Wurzburg Medizinische Klinik und Poliklinik II, Würzburg, Not set

Ospedali Riuniti di Ancona, Ancona, Not set

Azienda Ospedaliero Universitaria Di Bologna Policlinico Sorsola Malpighi, Bologna, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Not set

Fondazione Monza e Brianza per il Bambino e la sua Mamma (MBBM), Monza, Not set

Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale, Naples, Not set

Local Institution - 07500, Roma, Not set

Ospedale Pediatrico Bambino Gesu, Rome, Not set

Istituto Clinico Humanitas, Rozzano (MI), Not set

Local Institution - 07610, Torino, Not set

Azienda Sanitaria Ospedaliera San Giovanni Battista Molinette, Turin, Not set

Hokkaido University Hospital, Sapporo-shi, Hokkaido

National Cancer Center Hospital, Chuo-ku, Tokyo

Toranomon Hospital, Minato-ku, Tokyo

Local Institution - 13202, Bunkyo-ku, Not set

Kyushu University Hospital, Fukuoka, Not set

Tokai University Hospital, Isehara City, Kanagawa, Not set

Nagoya City University Hospital, Nagoya, Not set

Osaka Metropolitan university Hospital, Osaka, Not set

Japan Red Cross Medical Center, Shibuya-ku, Not set

Jichi Medical University Hospital, Shimotsuke, Not set

Local Institution - 13804, Shinjuku City, Not set

Local Institution - 04650, Amsterdam, Not set

Erasmus Medical Center - Daniel den Hoed, Rotterdam, Not set

Local Institution - 04400, Utrecht, Not set

Oslo Universitetssykehus, Oslo, Not set

Institutul Clinic Fundeni, Bucuresti, Not set

Hospital Universitario Vall D hebron, Barcelona, Not set

Hospital Universitari Germans Trias i Pujol ICO Badalona, Barcelona, Not set

Institut Clinic de Nefrologia i Urologia - Hospital Clinic i Provincial de Barcelona, Barcelona, Not set

Hospital San Joan de Deu Barcelona, Esplugues de Llobregat, Not set

Hospital Infantil Universitario Nino Jesus, Madrid, Not set

Hospital 12 De Octubre, Madrid, Not set

Clinica Universidad de Navarra, Pamplona, Not set

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca, Not set

Hospital Virgen Del Rocio, Sevilla, Not set

Karolinska University Hospital Huddinge, Stockholm, Not set

Inselspital Bern, Bern, Not set

Local Institution - 10850, Leeds, Not set

Kings College Hospital, London, Not set

UCL Cancer Institute, London, Not set

Christie Hospital Nhs Trust, Manchester Withington, Not set

Somers Cancer Research Building, Shirley Southampton, Not set

Conditions: Neoplasms

Learn More ›

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

NCT05451043

Recruiting

A single-arm, interventional study combining Immunotherapy and propranolol with/without chemotherapy and propranolol 1. Pancreatic Cancer Durvalumab will be administered once every 4 weeks, in combination with gemcitabine + nab-paclitaxel (day 1/8/15) and continuous propranolol. Tremelimumab will be given on day 1 of cycle 1, which may be repeated at the time of progression in eligible patients. 2. HCC Durvalumab will be administered once every 4 weeks in combination with continuous propranolol... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/24/2025

Locations: Cross Cancer Institute, Edmonton, Alberta

Conditions: Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer, Cholangiocarcinoma

Learn More ›

Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

NCT05501886

Recruiting

This is a Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of gedatolisib plus fulvestrant with or without palbociclib for the treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and aromatase inhibitor therapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/23/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama +216 locations

University of Alabama at Birmingham, Birmingham, Alabama

Arizona Oncology (US Oncology/McKesson) - Goodyear, Goodyear, Arizona

St. Bernards Medical Center, Jonesboro, Arkansas

CARTI Cancer Center, Little Rock, Arkansas

Pacific Cancer Medical Center Inc, Anaheim, California

Kaiser Permanente South Bay Medical Center, Harbor City, California

Cancer and Blood Specialty Clinic, Los Alamitos, California

Pacific Cancer Care, Monterey, California

University of California, Irvine Medical Center, Orange, California

Ventura County Hematology Oncology Specialists, Oxnard, California

Redlands Hematology Oncology, Redlands, California

UCLA Hematology/Oncology-Santa Monica, Santa Monica, California

Torrance Memorial Physician Network - Cancer Care, Torrance, California

Kaiser Permanente Medical Center - Vallejo, Vallejo, California

PIH Health Hospital Whittier, Whittier, California

Yale Cancer Center - New Haven, New Haven, Connecticut

South Broward Hospital District d/b/a Memorial Healthcare System, Hollywood, Florida

Cancer Specialists of North Florida - Jacksonville, Jacksonville, Florida

H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida

Bond & Steele Clinic, P.A. d/b/a Bond Clinic, P.A., Winter Haven, Florida

John D. Archbold Memorial Hospital, Thomasville, Georgia

Illinois Cancer Specialists - Arlington Heights, Arlington Heights, Illinois

Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana

University of Kentucky Medical Center, Lexington, Kentucky

Mercy Health - Paducah, Paducah, Kentucky

American Oncology Partners of Maryland, PA, Bethesda, Maryland

Maryland Oncology Hematology, P.A. - Rockville, Rockville, Maryland

Dana Farber Cancer Institute, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Henry Ford Hospital, Detroit, Michigan

Nebraska Hematology - Oncology, P.C., Lincoln, Nebraska

Oncology Hematology West PC dba Nebraska Cancer Specialists, Omaha, Nebraska

University of Nebraska Medical Center, Omaha, Nebraska

New York Oncology Hematology, P.C. - Albany, Albany, New York

Montefiore Medical Center, Bronx, New York

Queens Hospital Cancer Center, Jamaica, New York

Coleman, Pasmantier & Decter, MDs, New York, New York

Weill Cornell Medicine/New York-Presbyterian Hospital, New York, New York

University of Rochester Medical Center, Rochester, New York

Hematology/Oncology Associates of Central New York, Syracuse, New York

White Plains Hospital, White Plains, New York

Cone Health Cancer Center at Alamance Regional, Hematology/Oncology, Greensboro, North Carolina

Southeast Regional Cancer Center, Lumberton, North Carolina

University Hospitals Cleveland Medical Center, Cleveland, Ohio

The James Cancer Hospital and Solove Research Institute, Columbus, Ohio

OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma

Oregon Oncology Specialists, Salem, Oregon

Northwest Cancer Specialists, PC - Tigard, Tigard, Oregon

Consultants In Medical Oncology and Hematology, P.C., Broomall, Pennsylvania

Alliance Cancer Specialists PC, Horsham, Pennsylvania

Cancer Care Associates of York, York, Pennsylvania

Sanford Gynecologic Oncology Clinic, Sioux Falls, South Dakota

Texas Oncology - Austin, Austin, Texas

Texas Oncology P.A. - Dallas, Dallas, Texas

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas

William Beaumont Army Medical Center, El Paso, Texas

Oncology Consultants, Houston, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

Brooke Army Medical Center, Houston, Texas

Texas Oncology - McKinney, McKinney, Texas

Texas Oncology - Gulf Coast, Sugar Land, Texas

Texas Oncology - Tyler, Tyler, Texas

Fort Belvoir Community Hospital, Fort Belvoir, Virginia

Bon Secours St. Francis Medical Oncology Center, Midlothian, Virginia

Virginia Oncology Associates - Newport News, Newport News, Virginia

VCU Massey Cancer Center, Richmond, Virginia

Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care - Roanoke, Roanoke, Virginia

Fred Hutchinson Cancer Center, Seattle, Washington

Northwest Medical Specialties, PLLC - Tacoma, Tacoma, Washington

Alexander Fleming Institute, Buenos Aires, Not set

Buenos Aires British Hospital, Buenos Aires, Not set

CENIT Foundation, Buenos Aires, Not set

Center for Medical Education and Clinical Research (CEMIC), Buenos Aires, Not set

Fleischer Medical Center, Buenos Aires, Not set

Medical Center Austral, Buenos Aires, Not set

Pergamino Clinic, Buenos Aires, Not set

Cordoba Oncology Institute (IONC), Córdoba, Not set

Center of Nuclear and Molecular Medicine of Entre Rios (CEMENER), Paraná, Not set

CEDIT Diagnostic and treatment center, Salta, Not set

CER San Juan, San Juan, Not set

Rosario's Oncology Institute and Medical Specialities (IOR), Santa Fe, Not set

9 of July Sanatorium, Tucumán, Not set

Adelaide Oncology & Haematology, Adelaide, Not set

St Vincent's Hospital (Melbourne) Ltd, Fitzroy, Not set

Peninsula & South Eastern Hematology and Oncology Group (PSEHOG), Frankston, Not set

Hollywood Private Hospital, Breast Cancer Research Centre, Nedlands, Not set

Mater Hospital Brisbane, Mater Cancer Care Centre, South Brisbane, Not set

Icon Cancer Centre- Southport, Southport, Not set

Sydney Adventist Hospital, Wahroonga, Not set

The Queen Elizabeth Hospital, Woodville, Not set

University Hospital Graz, Department of Gynecology and Obstetrics, Graz, Not set

University Hospital Innsbruck - Tyrolean Hospital, Department of Gynaecology and Obstetrics, Innsbruck, Not set

Order Hospital Linz Ltd. - Hospital of Sisters of Mercy, Department of Internal Medicine I, Linz, Not set

Salzburg Regional Hospital, Department of Internal Medicine III, Salzburg, Not set

University Hospital St. Poelten, Department of Internal Medicine I, St. Poelten, Not set

Hospital Hietzing, Department of Gynecology, Vienna, Not set

Medical University Vienna, Department of Gynecology and Obstetrics, Vienna, Not set

Saint Luc University Hospital, Brussels, Not set

Charleroi Grand Hospital (GHDC), Charleroi, Not set

University Hospital Antwerp (UZA), Edegem, Not set

AZ Groeninge, Kortrijk, Not set

University Hospitals Leuven, Campus Gasthuisberg, Leuven, Not set

Citadelle Regional Hospital Center, Liège, Not set

VITAZ, Sint-Niklaas, Not set

Centre Hospitalier Peltzer-la-Tourelle, Verviers, Not set

UCL Mont-Godinne University Hospitals, Yvoir, Not set

Oncology Treatment Center, Belém, Pará

Pronutrir, Fortaleza, Not set

ONCOSITE - Clinical Research Center in Oncology, Ijuí, Not set

Juiz de Fora Eurolatino Research Center, Minas Gerais, Not set

Bahia Oncology Center, Salvador de Bahia, Not set

D'OR Institute, São Paulo, Not set

Hospital A.C.Camargo, São Paulo, Not set

Multiprofile Hospital for Active Treatment - Uni Hospital, Panagyurishte, Panagyurishte, Not set

MHAT for Women's Health "Nadezhda", Sofia, Not set

Multiprofile Hospital for Active Treatment "Serdika", Sofia, Sofia, Not set

Specialized Hospital for Active Treatment in Oncology, Clinic of Medicial Oncology (Chemotherapy), Sofia, Not set

University Multiprofile Hospital for Active Treatment "Sveta Marina", Varna, Not set

BC Cancer - Vancouver, Medical Oncology, Vancouver, British Columbia

CIUSSS du Saguenay Lac St-Jean, Chicoutimi, Quebec

Hospital Notre-Dame, Montréal, Quebec

Maisonneuve-Rosemont Hospital, Montréal, Quebec

University Hospital Olomouc, Clinic of Oncology, Olomouc, Not set

Thomayer University Hospital, Clinic of Oncology, Prague, Not set

University Hospital Bulovka, Institute of Radiation Oncology, Prague, Not set

University Hospital Motol, Clinic of Oncology, Prague, Not set

Bergonie Institute, Bordeaux, Not set

Francois Baclesse Center, Caen, Not set

La Roche-sur-Yon Hospital, La Roche-sur-Yon, Not set

CHU La Timone - La Timone Children's Hospital, Marseille, Not set

University Hospital Center of Poitiers, Poitiers, Not set

Saint Anne Clinic, Strasbourg, Not set

Gustave Roussy, Villejuif, Not set

Hospital Bayreuth, Bayreuth, Not set

Vivantes Hospital Am Urban, Berlin, Not set

Private Practice with Focus on Oncology, Luebeck, Not set

University Hospital Johannes Gutenberg - University of Mainz, Mainz, Not set

Hospital Suedstadt Rostock, Mecklenburg, Not set

University Hospital Muenster, Münster, Not set

Caritas Klinikum, Saarbrücken, Not set

Helios Clinic Wuppertal, Wuppertal, Not set

Alexandra General Hospital, Athens, Not set

University General Hospital of Ioannina, Ioánnina, Not set

IASO Thessaly SA, Larissa, Not set

EUROMEDICA General Clinic of Thessaloniki, Thessaloníki, Not set

Theageneio Anticancer Hospital of Thessaloniki, Thessaloníki, Not set

University of Debrecen Clinical Center, Institute of Oncology, Debrecen, Not set

Bacs-Kiskun County Hospital, Center for Oncoradiology, Kecskemét, Not set

Szabolcs-Szatmar-Bereg County Hospitals and University Teaching Hospital, Department of Oncology, Nyíregyháza, Not set

HCG Cancer Centre, Bangalore, Not set

Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, Not set

Tata Medical Center, Kolkata, Not set

Tata Memorial Hospital, Navi Mumbai, Not set

Christian Medical College, Department of Medical Oncology, Vellore, Not set

European Institute of Oncology (IEO), IRCCS, Milan, Not set

University Polyclinic Hospital of Modena, Modena, Not set

Local Healthcare Company of Monza (ASST Monza), Monza, Not set

University Hospital of Parma, Parma, Not set

New Hospital of Prato (NOP), Prato, Not set

University Hospital Campus Bio-Medico, Rome, Not set

University Polyclinic Foundation "Agostino Gemelli" - IRCCS, Rome, Not set

Santa Maria della Misericordia University Hospital of Udine, Udine, Not set

Asan Medical Center, Seoul, Not set

Gangnam Severance Hospital, Soeul, Not set

Korea University Anam Hospital, Soeul, Not set

Samsung Medical Center, Soeul, Not set

Severance Hospital, Yonsei University Health System, Soeul, Not set

Ulsan University Hospital, Ulsan, Not set

Clinical Research Center Chapultepec Mexico City, Mexico City, Not set

CRYPTEX, Mexico City, Not set

ProcliniQ Clinical Research, Mexico City, Not set

Filios High Medicine, Monterrey, Not set

Administrative Society of Health Services, SC, Morelia, Not set

Avix Clinical Research, Nuevo León, Not set

Zambrano Hellion Medical Center, Nuevo León, Not set

Inbiomedyc, Querétaro, Not set

ONCOR Life Medical Center, Saltillo, Not set

Prof. Franciszek Lukaszczyk Oncology Center in Bydgoszcz, Chemotherapy Outpatient Clinic, Bydgoszcz, Not set

Medical Clinic "Komed", Konin, Not set

Maria Sklodowska-Curie Institute of Oncology, Branch in Krakow, Kraków, Not set

Independent Public Healthcare Facility Prof. Tadeusz Koszarowski Opole Oncology Center in Opole, Clinical Oncology Department and Day Hospitalization Unit, Opole, Not set

St. John Paul 2nd Mazovian Provincial Hospital in Siedlce Limited Liability Company, Siedlce Oncology Centre, Siedlce, Not set

West Pomeranian Oncology Center, Szczecin, Not set

LUX MED Oncology LLC, Szamocka Hospital, Department of Clinical Oncology/Chemotherapy, Warsaw, Not set

Maria Sklodowska-Curie - National Research Institute of Oncology, Warsaw, Not set

Provincial Specialist Hospital in Wroclaw, Department of Chemotherapy, Wroclaw, Not set

Polish Mother's Memorial Hospital-Research Institute, Łódź, Not set

S.C. Oncopremium-Team SRL, Baia Mare, Not set

Prof. Dr. Alexandru Trestioreanu Institute of Oncology, Bucharest, Not set

Prof. Dr. Ion Chiricuta Institute of Oncology, Cluj-Napoca, Not set

Onco Clinic Consult S.A., Craiova, Not set

Oncology Center "Sf. Nectarie", Craiova, Not set

S.C. Topmed Medical Center SRL, Târgu-Mureş, Not set

Curie Oncology, Singapore, Not set

ICON SOC Farrer Park Medical Clinic, Singapore, Not set

OncoCare Cancer Centre, Singapore, Not set

Raffles Hospital, Singapore, Not set

Tan Tock Seng Hospital, Singapore, Not set

Infanta Cristina Hospital, Badajoz, Not set

Catalan Institute of Oncology, Hospital Duran i Reynals, Barcelona, Not set

Caceres Hospital Complex - San Pedro de Alcantara General Hospital, Cáceres, Not set

Hospital Ruber Internacional, Madrid, Not set

University Hospital Foundation Jimenez Diaz, Madrid, Not set

University Clinical Hospital Virgen de la Arrixaca, Department of Oncology, Murcia, Not set

University Hospital Complex of Santiago (CHUS), Department of Oncology, Santiago De Compostela, Not set

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Not set

Taipei Medical University - Shuang Ho Hospital, New Taipei City, Not set

China Medical University Hospital, Taichung, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Royal United Hospital, Department of Oncology/Hematology, Bath, Not set

Velindre Cancer Centre, Cardiff, Not set

Guy's Hospital, London, Not set

Royal Marsden Hospital - London, Department of Medical Oncology, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Nottingham City Hospital, Nottingham, Not set

Conditions: Breast Cancer

Learn More ›

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

NCT06486441

Recruiting

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer who have received prior treatment with platinum-based chemotherapy and immunotherapy, versus the treatment of physician's choice (TPC). The primary objectives of this study are to evaluate the effect of SG compared to TPC on progression-free survival (PFS) as assessed by blinded independent central review (BICR) and overall survival (OS).

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

06/23/2025

Locations: University of Arkansas for Medical Sciences, Little Rock, Arkansas +170 locations

University of Arkansas for Medical Sciences, Little Rock, Arkansas

City of Hope, Duarte, California

UC San Diego Medical Center, La Jolla, California

Stanford Women's Cancer Center, Palo Alto, California

Kaiser Permanente Medical Center, Vallejo, California

University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora, Colorado

Hartford HealthCare Cancer Institute at Hartford Hospital, Hartford, Connecticut

Yale University School of Medicine, New Haven, Connecticut

Florida Cancer Specialists, Fort Myers, Florida

University of Florida, Gainesville, Florida

Baptist MD Anderson Cancer Center, Jacksonville, Florida

Tampa General Hospital (Cancer Institute), Tampa, Florida

Winship Cancer Institute, Emory University, Atlanta, Georgia

Lewis Cancer & Research Pavilion at St. Joseph's/Candler Health System, Savannah, Georgia

Northwestern Memorial Hospital, Chicago, Illinois

University of Chicago Medical Center, Chicago, Illinois

Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana

Baptist Health Lexington, Lexington, Kentucky

Norton Cancer Institute, Louisville, Kentucky

Women's Cancer Care, Covington, Louisiana

Ochsner Clinic Foundation, New Orleans, Louisiana

Greater Baltimore Medical Center, Baltimore, Maryland

Tufts Medical Center, Boston, Massachusetts

Massachusetts General Hospital, Boston, Massachusetts

Baystate Medical Center, Springfield, Massachusetts

West Michigan Cancer Center, Kalamazoo, Michigan

M Health Fairview University of Minnesota Medical Center - East Bank Hospital, Minneapolis, Minnesota

Metro Minnesota Community Oncology Research Consortium (MMCORC), Saint Louis Park, Minnesota

MidAmerica Division, Inc. c/o Research Medical Center, Kansas City, Missouri

Rutgers Cancer Institute, New Brunswick, New Jersey

University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico

Roswell Park Cancer Institute, Buffalo, New York

Northwell Health Cancer Institute, Lake Success, New York

Columbia University Medical Center, Herbert Irving Pavilion, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

SUNY Upstate Medical University, Syracuse, New York

Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina

Cleveland Clinic, Cleveland, Ohio

Ohio Health Research Institute, Columbus, Ohio

Oklahoma Cancer Specialists and Research Institute - OCSRI - Tulsa, Tulsa, Oklahoma

Providence Cancer Institute Franz Clinic, Portland, Oregon

Alliance Cancer Specialists, PC, Horsham, Pennsylvania

University of Pennsylvania Health System, Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania

MUSC Hollings Cancer Center, Charleston, South Carolina

SCRI Oncology Partners, Nashville, Tennessee

University of Texas Southwestern Medical Center, Dallas, Texas

Texas Oncology, Fort Worth, Texas

Baylor College of Medicine Medical Center, Houston, Texas

University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia

Virginia Oncology Associates, Norfolk, Virginia

Fred Hutchinson Cancer Center, Seattle, Washington

University of Wisconsin Carbone Cancer Center, Madison, Wisconsin

Froedtert and the Medical College of Wisconsin (MCW), Milwaukee, Wisconsin

Chris O'Brien Lifehouse, Camperdown, New South Wales

Mater Cancer Care Centre, South Brisbane, Queensland

Monash Health, Clayton, Victoria

Peter MacCallum Cancer Centre, Melbourne, Victoria

Sir Charles Gairdner Hospital, Murdoch, Western Australia

Clínica de Neoplasias Litoral, Itajai, Not set

Ensino e Terapia de Inovação Clínica AMO - ETICA, Salvador, Not set

London Health Sciences Centre, London, Not set

McGill University Health Centre - Glen Site, Montreal, Not set

CIC-CHU de Québec-Université Laval- Hôpital de l'Enfant-Jésus, Quebec, Not set

Sunnybrook Research Institute, Toronto, Not set

Princess Margaret Cancer Centre, Toronto, Not set

Beijing Cancer Hospital, Beijing, Not set

The First Hospital of Jilin University, Changchun, Not set

Hunan Cancer Hospital, Changsha, Not set

West China Second Hospital of Sichuan University, Chengdu, Not set

Chongqing University Cancer Hospital, Chongqing, Not set

Guangxi Medical University Affiliated Tumor Hospital, Guangxi Zhuang Autonomous Region, Not set

Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Not set

Women's Hospital School Of Medicine Zhejiang University, Hangzhou, Not set

Zhejiang Cancer Hospital, Hangzhou, Not set

Harbin Medical University Cancer Hospital, Harbin, Not set

Jiangxi Maternal and Child Health Hospital, Nanchang, Not set

Fudan University Shanghai Cancer Center, Shanghai, Not set

Shanghai Tenth People's Hospital, Shanghai, Not set

Tianjin Medical University Cancer Institute & Hospital, Tianjin, Not set

Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, Not set

Tongji Hospital, Tongji Medical College of HUST, Wuhan, Not set

The First Affiliated Hospital of Xian Jiaotong University, Xi'an, Not set

Henan Cancer Hospital, Zhengzhou, Not set

Nemocnice AGEL, Nový Jičín a.s., Nový Jičín, Not set

General University Hospital in Prague, Prague, Not set

University Hospital Bulovka, Prague, Not set

Centre Francois Baclesse, Caen Cedex 5, Not set

Institut Paoli Calmettes, Marseille, Not set

Centre Antoine Lacassagne, Nice, Not set

Hôpital Cochin, Paris, Not set

HCL - Centre Hospitalier Lyon Sud, Pierre Benite, Not set

ICO - Centre René Gauducheau, Saint-Herblain, Not set

Institut de Cancerologie de Lorraine, Vandoeuvre Les Nancy, Not set

Institut Gustave Roussy, Villejuif, Not set

Hochtaunus Kliniken Bad Homburg, Bad Homburg, Not set

Universitatsklinikum Dusseldorf, Düsseldorf, Not set

University Hospital Essen, Essen, Not set

Universitätsklinikum Hamburg, Hamburg, Not set

Medical School Hannover, Hannover, Not set

University Hospital Leipzig, Leipzig, Not set

Klinikum rechts der Isar der TU München, Klinik und Poliklinik für Frauenheilkunde, München, Not set

Universitätsklinikum Ulm, Ulm, Not set

Aretaeion Hospital, Athens, Not set

Kalamata Hospital, Kalamata, Not set

General Hospital of Patras Agios Andreas, Patras, Not set

St. Luke's Hospital, Thessaloniki, Not set

Hong Kong Sanatorium & Hospital, Happy Valley, Not set

Queen Mary Hospital, Hong Kong, Not set

Prince of Wales Hospital, New Territories, Not set

Hillel Yaffe Medical Center, Hadera, Not set

Rambam Health Care Campus, Haifa, Not set

Wolfson Medical Center, Holon, Not set

Hadassah Medical Center, Jerusalem, Not set

Sheba Medical Center, ramat GAn, Not set

Sourasky T.A.M.C., Tel Aviv-Yaffo, Not set

SOC di Oncologia Medica e Prevenzione Oncologica Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Not set

Azienda Ospedaliera Universitaria Careggi - Unita di Oncologia Ginecologica, Firenze, Not set

ASST Lecco - Ospedale Alessandro Manzoni, Lecco, Not set

Istituto Romagnolo per lo Studio dei Tumori-Dino Amadori - IRST, Meldola, Not set

Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano, Milano, Not set

Irccs Ospedale San Raffaele-UO Ginecologia, Milan, Not set

Istituto Europeo di Oncologia, Milan, Not set

Istituto Oncologico Veneto IRCCS, Padova, Not set

Azienda Ospedaliero Universitaria Pisana, Ospedale Santa Chiara, Pisa, Not set

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Not set

Istituto Nazionale Tumori Regina Elena IRCCS, Rome, Not set

AOU Città della Salute e della Scienza di Torino - Presidio Sant'Anna, Torino, Not set

A.O. Ordine Mauriziano di Torino, Torino, Not set

Chiba Cancer Center, Chiba, Not set

The Jikei University Kashiwa Hospital, Chiba, Not set

Hyogo Cancer Center, Hyogo, Not set

St. Marianna University Hospital, Kanagawa, Not set

Mie University Hospital, Mie, Not set

Okayama University Hospital, Okayama, Not set

Saitama Medical University International Medical Center, Saitama, Not set

Shizuoka Cancer Center, Shizuoka, Not set

National Cancer Center Hospital, Tokyo, Not set

The Cancer Institute Hospital Of JFCR, Tokyo, Not set

Keimyung University Dongsan Medical Center, Dalseo-gu, Not set

National Cancer Center - Korea, Goyang-si, Not set

Seoul National University Hospital, Seoul, Not set

Asan Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Severance Hospital, Seoul, Not set

Szpitale Pomorskie Sp. z o.o., Gdynia, Not set

Uniwersyteckie Centrum Kliniczne SUM, Katowice, Not set

Mazowiecki Szpital Wojewódzki im. św. Jana Pawła II w Siedlcach, Siedlce, Not set

National University Hospital, Singapore, Not set

National Cancer Centre Singapore, Singapore, Not set

Complexo Hospitalario Universitario A Coruna, A Coruña, Not set

Hospital Clinic de Barcelona, Barcelona, Not set

Hospital Universitario Ciudad de Jaen, Jaén, Not set

Hospital General Universitario Gregorio Maranon, Madrid, Not set

Hospital Universitario Ramón y Cajal, Madrid, Not set

Hospital Universitario Clinico San Carlos, Madrid, Not set

Hospital Universitario Virgen de la Victoria, Málaga, Not set

Hospital Universitari Son Espases, Palma, Not set

Hospital Parc Taulí, Sabadell, Not set

Hospital Universitario Donostia, San Sebastián, Not set

Hospital Universitario La Fe - Valencia, Valencia, Not set

Kaohsiung Veterans General Hospital, Kaohsiung, Not set

Taichung Veterans General Hospital, Taichung, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Mackay Memorial Hospital, Taipei, Not set

Chang Gung Memorial Hospital, Linkou, Taoyuan City, Not set

Cambridge University Hospitals NHS Foundation Trust, Cambridge, Not set

Leeds Teaching Hospitals NHS Trust, Leeds, Not set

University Hospitals of Leicester NHS Trust-Leicester Royal Infirmary, Leicester, Not set

University College London Hospitals, London, Not set

East and North Hertfordshire NHS Trust - Mount Vernon Cancer Centre, Northwood, Not set

Conditions: Endometrial Cancer

Learn More ›

Assessing Interventions of Diet in IBD

NCT06773182

Recruiting

In this study, we are trying to learn how certain diets affect people with inflammatory bowel disease (IBD). We want to understand what makes it hard or easy for them to stick to different eating plans, like intermittent fasting, the Mediterranean diet, and the Low FODMAP diet. By finding out how these diets help with symptoms and which ones are easier to follow, we hope to improve the quality of life for people with IBD.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/23/2025

Locations: 2F Digestive Diseases Clinic - Hamilton Health Science, Hamilton, Ontario +2 locations

Conditions: IBD (Inflammatory Bowel Disease), Ulcerative Colitis (UC), Crohn Disease (CD)

Learn More ›

Statins for Venous Event Reduction in Patients With Venous Thromboembolism

NCT04319627

Recruiting

The standard or usual treatment for patients diagnosed with deep vein thrombosis or pulmonary embolism is treatment with blood thinners (called anticoagulants). While treatment of blood clots with blood thinners is effective, some research has shown that adding a statin (medication used to lower cholesterol) may give extra protection. It is thought that statins can improve how cells along the walls of the vein control inflammation, which can prevent new blood clots from forming. The medication... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/23/2025

Locations: Foothills Medical Centre, Calgary, Alberta +17 locations

Conditions: Venous Thromboembolism, Blood Clot, Post Thrombotic Syndrome

Learn More ›

SNV4818 in Participants With Advanced Solid Tumors

NCT06736704

Recruiting

This study is testing a new medicine, SNV4818, for people with advanced cancers. The researchers want to find out if SNV4818 is safe, well-tolerated, and effective in treating solid tumors. They are investigating different doses in order to find the safest and most effective one.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/23/2025

Locations: Thomas Jefferson University-Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania +9 locations

Conditions: Advanced Solid Tumors

Learn More ›

A Study of Navenibart in Participants With Hereditary Angioedema

NCT06842823

Recruiting

This is a Phase 3 multicenter, randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of subcutaneous administration of navenibart in adult and adolescent participants with type 1 or type 2 hereditary angioedema (HAE). The goal of this clinical trial is to evaluate the efficacy and safety of navenibart compared to placebo in preventing HAE attacks in participants with HAE.

Gender:

ALL

Ages:

12 years and above

Trial Updated:

06/23/2025

Locations: Site 9, Birmingham, Alabama +13 locations

Conditions: Hereditary Angioedema (HAE)

Learn More ›

A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

NCT02991469

Recruiting

Primary Objective: To describe the pharmacokinetic (PK) profile of sarilumab in patients aged 1-17 years with Systemic Juvenile Idiopathic Arthritis (sJIA) in order to identify the dose and regimen for adequate treatment of this population. Secondary Objective: To describe the pharmacodynamics (PD) profile, the efficacy, and the long term safety of sarilumab in patients with sJIA.

Gender:

ALL

Ages:

Between 1 year and 17 years

Trial Updated:

06/23/2025

Locations: Investigational Site Number : 0320004, San Miguel de Tucumán, Tucumán +26 locations

Investigational Site Number : 0320004, San Miguel de Tucumán, Tucumán

Investigational Site Number : 1000001, Plovdiv, Not set

Investigational Site Number : 1240110, Calgary, Alberta

Investigational Site Number : 1240112, Montreal, Quebec

Investigational Site Number : 2460040, Helsinki, Not set

Investigational Site Number : 2500041, Bron, Not set

Investigational Site Number : 2500042, Montpellier, Not set

Investigational Site Number : 2500040, Paris, Not set

Investigational Site Number : 2760064, Berlin, Not set

Investigational Site Number : 2760065, Berlin, Not set

Investigational Site Number : 2760062, Hamburg, Not set

Investigational Site Number : 2760060, Sankt Augustin, Not set

Investigational Site Number : 2760063, Sendenhorst, Not set

Investigational Site Number : 3720001, Dublin, Not set

Investigational Site Number : 3800051, Genoa, Genova

Investigational Site Number : 3800054, Milan, Milano

Investigational Site Number : 3800052, Rome, Roma

Investigational Site Number : 6430001, Moscow, Not set

Investigational Site Number : 6430062, Moscow, Not set

Investigational Site Number : 6430063, Moscow, Not set

Investigational Site Number : 6430065, UFA, Not set

Investigational Site Number : 7240050, Esplugues de Llobregat, Barcelona [Barcelona]

Investigational Site Number : 7240053, Madrid, Not set

Investigational Site Number : 7240051, Valencia, Not set

Investigational Site Number : 8260031, London, London, City Of

Investigational Site Number : 8260034, Leeds, Not set

Investigational Site Number : 8260033, Liverpool, Not set

Conditions: Juvenile Idiopathic Arthritis

Learn More ›

A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

NCT06643481

Recruiting

This is a multicenter, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early-stage ALS (within 2 years of ALS symptoms onset). The study comprises a core double-blind (DB) 40-week treatment period followed by an open label extension (OLE).

Gender:

ALL

Ages:

Between 18 years and 100 years

Trial Updated:

06/23/2025

Locations: University of California San Diego, La Jolla, California +43 locations

University of California San Diego, La Jolla, California

Keck Medical Center USC, Los Angeles, California

UC San Francisco Medical Center, San Francisco, California

Orlando Health Clinical Trials, Orlando, Florida

Emory University School of Medicine, Atlanta, Georgia

University Of Kansas Medical Center, Kansas City, Kansas

Massachusetts General Hospital, Boston, Massachusetts

Neurology Associates P C, Lincoln, Nebraska

Lange Neurology PC, New York, New York

University of Cincinnati Medical Center, Cincinnati, Ohio

The Ohio State University, Columbus, Ohio

AMR Knoxville, Knoxville, Tennessee

Nerve and Muscle Center of Texas, Houston, Texas

Novartis Investigative Site, North Ryde, New South Wales

Novartis Investigative Site, Randwick, New South Wales

Novartis Investigative Site, Herston, Queensland

Novartis Investigative Site, Cauldfield, Victoria

Novartis Investigative Site, SouthPort, Not set

Novartis Investigative Site, Leuven, Not set

Novartis Investigative Site, Liege, Not set

Novartis Investigative Site, Hamilton, Ontario

Novartis Investigative Site, Montreal, Quebec

Novartis Investigative Site, Beijing, Not set

Novartis Investigative Site, Aalborg, Not set

Novartis Investigative Site, Kobenhavn N V, Not set

Novartis Investigative Site, Nice, Not set

Novartis Investigative Site, Tours, Not set

Novartis Investigative Site, Luebeck, Not set

Novartis Investigative Site, Munchen, Not set

Novartis Investigative Site, Dublin, Not set

Novartis Investigative Site, Sendai city, Miyagi

Novartis Investigative Site, Yangsan Si, Gyeongsangnam Do

Novartis Investigative Site, Seoul, Not set

Novartis Investigative Site, Utrecht, Not set

Novartis Investigative Site, Bydgoszcz, Not set

Novartis Investigative Site, Krakow, Not set

Novartis Investigative Site, Warszawa, Not set

Novartis Investigative Site, Barcelona, Catalunya

Novartis Investigative Site, Malmo, Not set

Novartis Investigative Site, Umea, Not set

Novartis Investigative Site, Basel, Not set

Novartis Investigative Site, St Gallen, Not set

Novartis Investigative Site, London, Not set

Conditions: Amyotrophic Lateral Sclerosis (ALS)

Learn More ›

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

NCT05924477

Recruiting

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE) is a multi-center, outcome-masked, randomized clinical trial. The purpose of this study is to compare glaucoma drainage device implantation in the anterior chamber (front part of the eye) and sulcus (small space between iris and front chamber of the eye) in efforts to minimize cell loss in the eye.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/23/2025

Locations: University of California San Francisco, San Francisco, California +7 locations

Conditions: Glaucoma

Learn More ›